A distinct academic team with far-reaching experience to develop CBD Science Group’s clinical activities. Starting with our peer-reviewed protocols the Clinical Advisory Board will direct and advise on all clinical activities with the patient at the heart of any discussion.
Mike is the former Deputy Medical Director at NHS England and has wide-ranging experience including: planning, commissioning and providing services, leading clinical management teams on a local, regional and national basis.
Mike has also advised on policy for NHS England to the Secretary of State and government ministers.
Professor Sam Ahmedzai is the NIHR National Specialty Lead for Cancer: Supportive Care and Community-Based Research.
He was a professor of supportive and palliative care at the University of Sheffield for 20 years. He is the Chair of the National Cancer Research Institute (NCRI) Supportive and Palliative Care Clinical Studies Group.
Dr. Barry Laid holds positions as Senior Lecturer in Palliative Medicine at the University of Edinburgh and is a consultant in Palliative Medicine in Edinburgh Cancer Centre and St. Columba’s Hospice.
Barry leads a research programme examining the systemic inflammatory response in cachexia, symptom genesis, pain and prognosis in cancer. He has over 100 papers published.
Dr. Paul Farquhar-Smith is a Consultant in Pain Management and Anaesthetics at the Royal Marsden NHS Foundation Trust, London. He has a specific interest in pain in cancer survivors.
Paul runs the only dedicated CIPN clinic in the country. He was integral in the development of the Pain Database for the UK. His PhD was based on the role of medicinal cannabis in cancer-related pain.
Saoirse is a Professor of Pharmacology in the Faculty of Medicine & Health Sciences at the University of Nottingham.
Dr. O’Sullivan is a leading researcher in the field of cannabinoid research and was awarded the title of International Cannabinoid Research Society Young Investigator of the Year in 2016. She has published numerous papers on the role of cannabinoid receptors in health and disease.
Mike is the St. Gemma’s Professor of Palliative Medicine and works clinically as a consultant at St. Gemma’s Hospice in Leeds.
Mike has chaired the National Cancer Research Institute Palliative Care Studies Group from 2008 and has chaired scientific and organisational committees for several research congresses of the European Association for Palliative Care (EAPC).
